Latest filing published 16 Jan 2026 for InspireMD, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Scott R. Ward (chief executive) discloses dealings in 2 companies, chiefly Cardiovascular Systems Inc and InspireMD, Inc. Between 25 January 2016 and 14 January 2026, the trades on record add up to 15 filings.
On the market, this insider has only ever bought: 4 purchases, €110k in total. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants.
In size, the median ticket on the buying side is €40k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 16 January 2026 with a share grant in InspireMD, Inc. The most recent open-market purchase was published on 23 May 2022, 1,609 days ago. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations